// App-Quantinova.ai

CRA9508 : Outcome in adolescent and young adult (AYA) patients compared with younger patients treated for high-risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Childrens Oncology Group study AALL0232.

Researchers

Presenter

  • Eric Larsen

Principal Investigators

  • Elizabeth A. Raetz

  • Naomi Joan Winick

  • Wanda L. Salzer

  • James B. Nachman

  • Meenakshi Devidas

  • Stephen Hunger

  • William L. Carroll

Medical Centers

  • Children's Oncology Group, Gainesville, FL

  • Maine Childrens Cancer Program, Scarborough, ME

  • The University of Chicago Medical Center, Chicago, IL

  • University of Colorado Denver School of Medicine, Aurora, CO

  • New York University Medical Center, New York City, NY

  • Center for Cancer and Blood Disorders, Childrens Medical Center Dallas, Dallas, TX

  • National Institutes of Health, Silver Spring, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Down syndrome

Biomarkers

  • Hormone receptor

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Methotrexate

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved